Email Updates

You are here

AVAC in the News

  • Every Dec. 1, the world commemorates those who have died from an AIDS-related illness. Known as World AIDS Day, it serves as a reminder that there has been an ongoing pandemic for the past 40 years, pre-dating COVID. The COVID vaccines were sequenced, developed and approved in the US in record time, but that would not have been possible without decades of work by HIV researchers.

    December 1, 2021
    CNBC
  • The COVID-19 pandemic has complicated — and in some cases halted — the fight against HIV/AIDS. We talk about that impact with Hombisa Ntsikanye, an implementer and developer of the HIV and AIDS program at Blue Roof Life Space in Durban, South Africa; and Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition.

    December 1, 2021
    General
    CBC
  • Dr. Anthony Fauci, the top US infectious disease expert, said Tuesday the COVID-19 pandemic has diverted scientific and financial resources from the fight against AIDS, seriously impeding global efforts to achieve the UN goal of ending AIDS by 2030.

    December 1, 2021
    NBC News
  • In the US, women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.

    December 1, 2021
    National Geographic
  • There have been several shifts in the UNAIDS ethics guidance with implications for HIV vaccine researchers submitting applications for initial ethics review or re-certification, and for RECs conducting such reviews. This review may assist RECs in a more efficient and consistent application of ethics recommendations. However, additional tools and training may further help stakeholders comply with new UNAIDS ethics recommendations during protocol development and ethics review.

    November 21, 2021
    JIAS
  • Despite tremendous advances made in the global HIV response, overall progress in HIV prevention efforts remains too slow to reach the 2030 targets. In 2019 alone, 1.7 million people acquired HIV, three times more than the UNAIDS 2020 target. About 62 percent of the new infections were among key populations, these are men who have sex with men, sex workers, transgender people and people who inject drugs, and their sexual partners, and one in four new infections in sub-Saharan Africa are among adolescent girls and young women.

    November 21, 2021
    JIAS
  • HIVR4P // Virtual was held over the course of two weeks on 27-28 January and 3-4 February 2021 as the COVID-19 pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policy-makers, implementors and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from pre-clinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights.

    October 29, 2021
    General
    AIDS Research and Human Retroviruses
  • We were among the many advocates and global health leaders who called on the Biden Administration to move quickly in naming a permanent head for the US President’s Emergency Plan for AIDS Relief. Now that President Biden has selected Dr. John Nkengasong as his nominee, Congress must act swiftly to confirm his nomination and give US global efforts to address HIV – a preventable and treatable disease that still claims nearly 700,000 lives a year around the world, four decades after the first case was discovered – the permanent leadership it needs and deserves.

    October 29, 2021
    General
    Science Speaks
  • COVID-19 has now killed about 730,000 people in the US, making it the deadliest pandemic in the nation's history, with more lives claimed than by HIV/AIDS. The tally comes as the US marks four decades since HIV — the virus that can cause AIDS — was first detected in the country, and some are now looking at the two vastly different diseases and seeing parallels. The US government's initial approach to both HIV/AIDS and COVID was denial and indifference.

    October 21, 2021
    General
    The National News
  • It is paradoxical that the speed in obtaining vaccines against COVID-19 is due, in large part, to the enormous advantage provided by research on HIV and its key technologies and that, however, we still continue without an immunization against the virus AIDS. To move forward, we need increased funding and consistent commitment from the industry.

    October 14, 2021
    Agencia SINC

Pages